HSCS HeartSciences Inc. - Common Stock
NASDAQ · Health Care close Oct 2, 2026HSCS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HSCS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| May 17, 2024 | 1-for-100 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2026 | $-0.86 | $-0.74 | -16.3% | |
| June 30, 2026 | $-0.87 | $-0.74 | -16.8% | |
| March 31, 2026 | $-0.63 | $-0.87 | 27.3% | |
| Dec. 31, 2025 | $-0.85 | $-2.01 | 57.8% | |
| Sept. 30, 2025 | $-1.58 | $-1.94 | 18.5% | |
| June 30, 2025 | $-1.88 | $-2.29 | 18.1% | |
| March 31, 2025 | $-2.57 | $-2.42 | -6.3% |
Institutional owners (13F) 16 filers · $443K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (0 vs prior Q) | 2 (+1 vs prior Q) | 1 (-2 vs prior Q) | 3 (+3 vs prior Q) | +14K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| TFB Advisors LLC | $74,647 | 29,740 | 16.86% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $57,852 | 23,049 | 13.06% | Shares |
| VANGUARD GROUP INC | $57,339 | 18,556 | 12.95% | Shares |
| Astoria Strategic Wealth, Inc. | $47,507 | 18,927 | 10.73% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,100 | 17,968 | 10.18% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $43,270 | 17,239 | 9.77% | Shares |
| Tradition Wealth Management, LLC | $42,216 | 16,819 | 9.53% | Shares |
| CITADEL ADVISORS LLC | $36,365 | 14,488 | 8.21% | Shares |
| CITIGROUP INC | $14,706 | 5,859 | 3.32% | Shares |
| UBS Group AG | $14,588 | 5,812 | 3.29% | Shares |
| Tower Research Capital LLC (TRC) | $3,936 | 1,568 | 0.89% | Shares |
| BlackRock, Inc. | $1,882 | 750 | 0.43% | Shares |
| Federation des caisses Desjardins du Quebec | $1,757 | 700 | 0.40% | Shares |
| OSAIC HOLDINGS, INC. | $1,631 | 650 | 0.37% | Shares |
| Caitong International Asset Management Co., Ltd | $20 | 8 | 0.00% | Shares |
| Financial Management Professionals, Inc. | $5 | 2 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Mark Hilz | June 14, 2023 | · | Initial filing | Passive investment | SEC |
| Andrew Simpson | June 14, 2023 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 6 insiders · 3 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrew Simpson | Chairman of the Board, President and Chief Executive Officer | Nov. 28, 2025 A | 74,382 | 0 | 0 | $0 |
| Danielle Watson | Chief Financial Officer | Dec. 22, 2025 A | · | 0 | 0 | $0 |
| HILZ MARK T | Chief Operating Officer and Secretary | Dec. 22, 2025 A | 4,752 | 0 | 0 | $0 |
| Bruce Bent | Director | Jan. 12, 2026 A | · | 0 | 0 | $0 |
| David R. Wells | Director | Jan. 12, 2026 A | · | 0 | 0 | $0 |
| Brian Szymczak | Director | Dec. 22, 2025 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 17,968 SH | Aug. 19, 2026 | Daily |
HSCS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-10-01Mean target $12.00 +179.1%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.